Company news
Anuh Pharma Limited (NSE:ANUHPHR) news
Anuh Pharma Limited news releases on 6ix. Latest, May 28, 2026: ANUHPHR: FY26 revenue rose 15.66% to ₹776 Cr, driven by exports and regulatory market expansion
Press releases & updates
ANUHPHR: FY26 revenue rose 15.66% to ₹776 Cr, driven by exports and regulatory market expansion
May 28, 2026
ANUHPHR: FY26 revenue rose, but profit and margins declined; bonus shares issued and dividend proposed
May 20, 2026
Anuh Pharma Says Maharashtra Facility Undergone Audit By EDQM
March 6, 2026
ANUHPHR: Q3 FY26 saw higher revenue, profit, and margins, plus a completed 1:1 bonus share issue
February 6, 2026
Anuh Pharma Granted Certificate Of Suitability From EDQM For Sulfadimethoxine
December 5, 2025
ANUHPHR: Revenue increased but net profit fell; bonus shares issued and governance policies updated
November 7, 2025
ANUHPHR: Sequential revenue and profit decline offset by year-over-year growth and leadership addition
August 11, 2025
ANUHPHR: Net profit declined despite revenue growth; 1:1 bonus issue and 30% dividend proposed
May 23, 2025
ANUHPHR: Revenue and profit declined in Q3 FY25, with EBITDA margin at 9.86%
February 7, 2025
ANUHPHR: Q2 FY25 delivered strong sequential growth in revenue, EBITDA, and EPS, with expanded capacity
November 8, 2024
ANUHPHR: Q1 FY25 saw lower revenue, profit, and margins, with no material audit issues reported
August 12, 2024